Bisacodyl Delayed-Release Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Bisacodyl Delayed-Release Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of bisacodyl (C22H19NO4).
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 1975 (CN 1-MAY-2020)
Cell: 1.0 mm
Sample solution: Macerate a portion of powdered Tablets, equivalent to 300 mg of bisacodyl, with 100 mL of acetone. Heat on a steam bath
to boiling, filter, and evaporate to about 20 mL. Add 200 mL of water, and warm the mixture on the steam bath, passing a stream of nitrogen over the surface to evaporate the acetone. After 30 min, cool the mixture, and filter through a sintered-glass funnel. Discard the filtrate, and dissolve the crystals in 50 mL of acetone. Evaporate the solution to about 15 mL, add about 75 mL of water, heat on a steam bath for 15 min, and then cool. Scratch the sides of the beaker to induce crystallization, filter the crystals, and dry at 100° for about 15 min. Using the crystals, prepare a solution (1 in 200) in chloroform.
Acceptance criteria: Meet the requirements
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 PROCEDURE
Buffer: 0.074 M sodium acetate in water, adjusted with 2.5% (v/v) acetic acid to a pH of 7.4
Mobile phase: Acetonitrile and Buffer (45:55)
Standard solution: 0.5 mg/mL of USP Bisacodyl RS in acetonitrile
Sample solution: Transfer a portion of finely powdered Tablets equivalent to 100 mg of bisacodyl, to a 200-mL volumetric flask, add 25 mL of water, and shake by mechanical means for 15 min followed by sonication for 15 min. Add 100 mL of acetonitrile, and shake by mechanical means for 15 min followed by sonication for 15 min. Dilute with acetonitrile to volume, mix, and filter.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 265 nm
Columns
Guard: Packing L2
Analytical: 3.9-mm x 30-cm; packing L1
Flow rate: 2 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of bisacodyl (C22H19NO4) in the portion of Tablets taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Bisacodyl RS in the Standard solution (mg/mL)
CU = nominal concentration of bisacodyl in the Sample solution (mg/mL)
Acceptance criteria: 90.0%-110.0%
4 PERFORMANCE TESTS
DISINTEGRATION (701): Proceed as directed for Delayed-Release (Enteric-Coated) Tablets. The Tablets do not disintegrate after 1 h of agitation in
simulated gastric fluid TS, but then disintegrate within 45 min in simulated intestinal fluid TS.
UNIFORMITY OF DOSAGE UNITS (905): Meet the requirements
5 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed containers at a temperature not exceeding 30°.
USP REFERENCE STANDARDS (11)
USP Bisacodyl RS

